Europe Pharmaceutical Contract Sales Organizations Market
The Europe Pharmaceutical Contract Sales Organizations Market size was valued at US$ 1,908.90 Mn in 2022 and is projected to reach US$ 3,474.97 Mn by 2030, growing at a CAGR of 7.8% during 2022 - 2030.
Report Coverage
- Services: Commercial Services, Non-Commercial Services
- Modules: Syndicated Modules, Dedicated Modules
- Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases
- End User: Biopharmaceutical Companies, Pharmaceutical Companies
US$ 1,908.90 Mn
Market size in 2022
US$ 3,474.97 Mn
Market Size by 2030
7.8%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Pharmaceutical Contract Sales Organizations Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Pharmaceutical Contract Sales Organizations Market Regional Analysis
6.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue 2020-2030 (US$ Million)
6.3 Europe Pharmaceutical Contract Sales Organizations Market Forecast Analysis
7. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Services
7.1 Commercial Services
- 7.1.1 Overview
- 7.1.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Non-Commercial Services
- 7.2.1 Overview
- 7.2.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Modules
8.1 Syndicated Modules
- 8.1.1 Overview
- 8.1.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Dedicated Modules
- 8.2.1 Overview
- 8.2.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by Therapeutic Area
9.1 Cardiovascular Disorders
- 9.1.1 Overview
- 9.1.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Oncology
- 9.2.1 Overview
- 9.2.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Metabolic Disorders
- 9.3.1 Overview
- 9.3.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Neurology
- 9.4.1 Overview
- 9.4.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Orthopedic Diseases
- 9.5.1 Overview
- 9.5.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Infectious Diseases
- 9.6.1 Overview
- 9.6.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Pharmaceutical Contract Sales Organizations Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Pharmaceutical Companies
- 10.2.1 Overview
- 10.2.2 Pharmaceutical Companies : Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Europe Pharmaceutical Contract Sales Organizations Market – Europe Analysis
11.1 Overview
11.2 Europe- 11.2.1 Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 UK: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.1.2 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.1.3 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.1.4 UK: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.2.2 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.2.3 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.2.4 Germany: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.3 France: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.3.2 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.3.3 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.3.4 France: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.4 Russia: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.4.2 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.4.3 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.4.4 Russia: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.5 Italy: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.5.2 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.5.3 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.5.4 Italy: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
- 11.2.1.6 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Services
- 11.2.1.6.2 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Modules
- 11.2.1.6.3 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by Therapeutic Area
- 11.2.1.6.4 Rest of Europe: Europe Pharmaceutical Contract Sales Organizations Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Aenova Holding GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 IQVIA Holdings Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 MaBico SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Pfizer Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Syneos Health Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.